安塞曲匹 T1928

Product Introduction
Bioactivity


英文名: Anacetrapib

描述: Anacetrapib (MK-0859) 是 CETP 的抑制剂，能够抑制 rhCETP (IC50:7.9±2.5 nM) 和 C13S CETP 突变型 (IC50:11.8±1.9 nM) 的活性。

细胞实验: Anacetrapib (ANA) is dissolved in DMSO and diluted with appropriate media[2]. Cells are seeded in a 96 well plate overnight prior to the treatment by different concentrations of CETP inhibitors (e.g., Anacetrapib) for 24 h. Cell viability is measured using the CellTiter-Glo Luminescent Cell Viability Assay kit. Four wells are evaluated under each experimental condition[2].

激酶实验: The inhibitory potency (IC50) of Dalcetrapib, Torcetrapib, and Anacetrapib to decrease CE transfer from HDL to LDL by rhCETP and C13S CETP is measured using a scintillation proximity assay kit. Briefly, [3H]CE-labeled HDL donor particles are incubated in the presence of purified CETP proteins (final concentration 0.5 μg/mL) and biotinylated LDL acceptor particles for 3 h at 37°C. Subsequently, streptavidin-coupled polyvinyltoluene beads containing liquid scintillation cocktail binding selectively to biotinylated LDL are added, and the amount of [3H]CE molecules transferred to LDL is measured by β counting[1].

体外活性: Anacetrapib对巨噬细胞胆固醇逆向转运有促进作用,可增加30%的排泄物胆固醇含量.处理异常仓鼠模型,持续处理2周,与对照组相比,Anacetrapib （60 mg/kg/day）使CETP活性下降94%,HDL-胆固醇上升47%,不影响非HDL胆固醇浓度.与对照组相比,Anacetrapib处理的仓鼠HDL显示ABCG1和SR-B1调节的流出物增多. [14C]Anacetrapib（10 mg/kg,p.o.）给药48 h后,鼠和猴分别恢复～80和90%放射性,但排泄物中放射性几乎无变化.

体内活性: Anacetrapib和抑制素联用时,既可提高HDL-胆固醇水平,也可降低LDL-胆固醇水平。Anacetrapib剂量依赖性地抑制CE从HDL3转变为HDL2。Anacetrapib对[14C]-dalcetrapibthiol与人类重组CETP的结合数无影响。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 50 mg/mL (78.43 mM)
Ethanol : 57 mg/mL(89.4 mM)


关键字: Cholesteryl ester transfer protein | inhibit | Inhibitor | CETP | MK0859 | Anacetrapib | MK 0859

相关产品: Torcetrapib | Granotapide | Dalcetrapib | Implitapide | CP-532623 | Obicetrapib | Dirlotapide | NAMI-A | Lomitapide | Lomitapide Mesylate

相关库: Drug Repurposing Compound Library | Bioactive Compounds Library Max | Fluorochemical Library | Inhibitor Library | Anti-Obesity Compound Library | Lipid Metabolism Compound Library | Target-Focused Phenotypic Screening Library | NO PAINS Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compound Library

安塞曲匹 T1928信息由TargetMol中国为您提供，如您想了解更多关于安塞曲匹 T1928报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途